Literature DB >> 9711802

Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza.

Z Chen1, Y Sahashi, K Matsuo, H Asanuma, H Takahashi, T Iwasaki, Y Suzuki, C Aizawa, T Kurata, S Tamura.   

Abstract

The ability of plasmid DNA encoding various influenza viral proteins from the A/PR/8/34 (H1N1) virus to protect against influenza was compared in BALB/c mice. The plasmid DNA encoded hemagglutinin (HA), neuraminidase (NA), matrix protein (M1), nucleoprotein (NP) or nonstructural protein (NS1) in a chicken beta-actin-based expression vector (pCAGGS). Each DNA was inoculated twice 3 weeks apart at a dose of 1 microgram per mouse by particle-mediated DNA transfer to the epidermis (gene gun). Seven days after a second immunization, mice were challenged with the homologous virus and the ability of each DNA to protect mice from influenza was evaluated by decreased lung virus titers and increased survival. Mice, given HA- or NA-expressing DNA, induced a high level of specific antibody response and protected well against the challenge virus. On the other hand, mice given M1-, NP-, or NS1-DNA failed to provide protection, although M1- and NP-DNAs did induce detectable antibody responses. These results indicate that both HA- and NA-expressing DNAs for the surface glycoproteins are most protective against influenza from among the various viral protein-expressing DNAs used here.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9711802     DOI: 10.1016/s0264-410x(98)00043-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  23 in total

1.  DNA vaccines for influenza virus: differential effects of maternal antibody on immune responses to hemagglutinin and nucleoprotein.

Authors:  T M Pertmer; A E Oran; J M Moser; C A Madorin; H L Robinson
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Recombinant wild-type and edmonston strain measles viruses bearing heterologous H proteins: role of H protein in cell fusion and host cell specificity.

Authors:  Kaoru Takeuchi; Makoto Takeda; Naoko Miyajima; Fumio Kobune; Kiyoshi Tanabayashi; Masato Tashiro
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  SUMO Modification Stabilizes Enterovirus 71 Polymerase 3D To Facilitate Viral Replication.

Authors:  Yan Liu; Zhenhua Zheng; Bo Shu; Jin Meng; Yuan Zhang; Caishang Zheng; Xianliang Ke; Peng Gong; Qinxue Hu; Hanzhong Wang
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

4.  The proteosomal degradation of fusion proteins cannot be predicted from the proteosome susceptibility of their individual components.

Authors:  Petr O Ilyinskii; Anatoli B Meriin; Vladimir L Gabai; Evgeny V Usachev; Alexei G Prilipov; Galini Thoidis; Alexander M Shneider
Journal:  Protein Sci       Date:  2008-04-14       Impact factor: 6.725

5.  Effect of immunization with plasmid DNA encoding for rinderpest virus matrix protein on systemic rinderpest virus infection in rabbits.

Authors:  B Pahar; B Sharma; A C Goel
Journal:  Vet Res Commun       Date:  2002-04       Impact factor: 2.459

6.  Prime-boost vaccination with a combination of proteosome-degradable and wild-type forms of two influenza proteins leads to augmented CTL response.

Authors:  P O Ilyinskii; A B Meriin; V L Gabai; O P Zhirnov; G Thoidis; A M Shneider
Journal:  Vaccine       Date:  2008-03-14       Impact factor: 3.641

7.  Built-in adjuvanticity of genetically and protein-engineered chimeric molecules for targeting of influenza A peptide epitopes.

Authors:  Nikola S Kerekov; Iva I Ivanova; Nikolina M Mihaylova; Maria Nikolova; Jozsef Prechl; Andrey I Tchorbanov
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

8.  A second CRM1-dependent nuclear export signal in the influenza A virus NS2 protein contributes to the nuclear export of viral ribonucleoproteins.

Authors:  Shengping Huang; Jingjing Chen; Quanjiao Chen; Huadong Wang; Yanfeng Yao; Jianjun Chen; Ze Chen
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

9.  Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus.

Authors:  Quanjiao Chen; Haimen Kuang; Huadong Wang; Fang Fang; Zhongdong Yang; Zhiping Zhang; Xianen Zhang; Ze Chen
Journal:  Virus Genes       Date:  2008-12-10       Impact factor: 2.332

10.  Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses.

Authors:  Hideki Hasegawa; Takeshi Ichinohe; Akira Ainai; Shin-Ichi Tamura; Takeshi Kurata
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.